• 762 Citations
  • 16 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Retinoblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tetrahymena thermophila Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Dyneins Medicine & Life Sciences
Cell Cycle Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

  • 762 Citations
  • 16 h-Index
  • 27 Article

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

Angus, S. P., Oblinger, J. L., Stuhlmiller, T. J., DeSouza, P. A., Beauchamp, R. L., Witt, L., Chen, X., Jordan, J. T., Gilbert, T. S. K., Stemmer-Rachamimov, A., Gusella, J. F., Plotkin, S. R., Haggarty, S. J., Chang, L. S., Johnson, G. L. & Ramesh, V., Jan 1 2018, In : Neuro-Oncology. 20, 9, p. 1185-1196 12 p.

Research output: Contribution to journalArticle

Neurofibromatosis 2
src-Family Kinases
Null Lymphocytes
Receptor Protein-Tyrosine Kinases
3 Citations

New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging

Brighton, H. E., Angus, S. P., Bo, T., Roques, J., Tagliatela, A. C., Darr, D. B., Karagoz, K., Sciaky, N., Gatza, M. L., Sharpless, N. E., Johnson, G. L. & Bear, J. E., Jan 15 2018, In : Cancer Research. 78, 2, p. 542-557 16 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Pharmaceutical Preparations
1 Citations

Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer

Collins, K. A. L., Stuhlmiller, T. J., Zawistowski, J. S., East, M. P., Pham, T. T., Hall, C. R., Goulet, D. R., Bevill, S. M., Angus, S. P., Velarde, S. H., Sciaky, N., Oprea, T. I., Graves, L. M., Johnson, G. L. & Gomez, S. M., Jan 1 2018, In : Oncotarget. 9, 21, p. 15480-15497 18 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Tumor Cell Line
8 Citations

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma: Neuro Oncol

McNeill, R. S., Canoutas, D. A., Stuhlmiller, T. J., Dhruv, H. D., Irvin, D. M., Bash, R. E., Angus, S. P., Herring, L. E., Simon, J. M., Skinner, K. R., Limas, J. C., Chen, X., Schmid, R. S., Siegel, M. B., Van Swearingen, A. E. D., Hadler, M. J., Sulman, E. P., Sarkaria, J. N., Anders, C. K., Graves, L. M. & 3 othersBerens, M. E., Johnson, G. L. & Miller, C. R., Apr 6 2017, In : Neuro-Oncology. 19, 11, p. 1469-1480 12 p.

Research output: Contribution to journalArticle

1-Phosphatidylinositol 4-Kinase
Protein Kinase Inhibitors
Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinase Kinases
26 Citations

Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex

Zawistowski, J. S., Bevill, S. M., Goulet, D. R., Stuhlmiller, T. J., Beltran Lopez, A. S., Olivares-Quintero, J. F., Singh, D., Sciaky, N., Parker, J., Rashid, N. U., Chen, X., Duncan, J. S., Whittle, M. C., Angus, S. P., Velarde, S. H., Golitz, B. T., He, X., Santos, C., Darr, D. B., Gallagher, K. & 5 othersGraves, L. M., Perou, C. M., Carey, L. A., Earp, H. S. & Johnson, G. L., Mar 1 2017, In : Cancer Discovery. 7, 3, p. 302-321 20 p.

Research output: Contribution to journalArticle

Positive Transcriptional Elongation Factor B
Mitogen-Activated Protein Kinase Kinases
Triple Negative Breast Neoplasms
Receptor Protein-Tyrosine Kinases